Gentamicin Sulfate

Reference

• 1) Antimicrobial Sub-MIC induces Staphylococcus aureus biofilm formation without affecting the bacterial count
  • R. Elawady, A.G. Aboulela, A. Gaballah, A.A. Ghazal, A.N. Amer, BMC Infect. Dis. 2024, 24, 1065.


Anwendung
Gentamicin: An Aminoglycoside Antibiotic with Potent Bactericidal Activities
Gentamicin, an aminoglycoside antibiotic, is isolated from Micromonospora purpurea, a genus of Gram-positive bacteria. It consists of a mixture of three isomers, gentamicin C1, gentamicin C1a and gentamicin C2. Gentamicin interacts with the 30S subunit of prokaryotic ribosomes, and then it inhibits bacterial growth by inhibiting protein synthesis. Gentamicin has activity against mostly Gram-negative bacteria including Pseudomonas, Proteus, Serratia, and the Gram-positive Staphylococcus. But, it is not used for Pneumococcus, Hemolytic streptococci, Bacteroides, Rickettsia and fungus. Gentamicin is widely used because of its potent bactericidal activities and less bacterial resistance, but it is well known to cause nephrotoxicity and hypacusis.

References

• The aminoglycosides
  • R. S. Edson, C. L. Terrell, Mayo Clin. Proc. 1999, 74, 519.
• Structural origins of gentamicin antibiotic action
  • S. Yoshizawa, D. Fourmy, J. D. Puglisi, EMBO J. 1998, 17, 6437.
• Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
  • K. L. LaPlante, M. J. Rybak, Antimicrob. Agents Chemother. 2004, 48, 4665.
• Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?
  • P. Balakumar, A. Rohilla, A. Thangathirupathi, Pharmacol. Res. 2010, 62, 179.
• Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery
  • A. L. Doadrio, E. M. B. Sousa, J. C. Doadrio, J. P. Pariente, I. Izquierdo-Barba, M. Vallet-Regı́, J. Controlled Release 2004, 97, 125.


PubMed Literatur